Tag: the war on (some) drugs

7 Chinese nationals charged in MASSIVE money laundering, human smuggling, drug trafficking operation

Seven Chinese nationals have been charged in connection to a conspiracy to cultivate as well as distribute marijuana in the Northeastern United States. They undertook this operation by using a network of single-family houses in Massachusetts as well as Maine, according to the Department of Justice (DOJ).  

A press release from the DOJ on the charges stated that Jianxiong Chen, 39; Yuxiong Wu, 36; Dinghui Li, 38; Dechao Ma, 35; Peng Lian Zhu, 35; Hongbin Wu, 35; and Yanrong Zhu, 47 were all charged in connection to the network distributing the drugs around the Northeast. Six of the defendants were taken into custody earlier this week, with Yanrong Zhu still on the run as a fugitive.  

Most of the Chinese nationals have been charged with money laundering as well as conspiracy, and some were also charged with bringing assisting with bringing foreign nationals to the US illegally.

US Attorney Leah B. Foley said of the charges, “This case pulls back the curtain on a sprawling criminal enterprise that exploited our immigration system and our communities for personal gain. These defendants allegedly turned quiet homes across the Northeast into hubs for a criminal enterprise – building a multi-million-dollar black-market operation off the backs of an illegal workforce and using our neighborhoods as cover. That ends today.” 

The DOJ further stated, “According to the charging documents, from in or about January 2020, the defendants allegedly owned, operated or partnered with a network of interconnected grow houses in Massachusetts and Maine to cultivate and distribute kilogram-sized quantities of marijuana in bulk. Specifically, the enterprise allegedly operated grow houses in Braintree, Mass.; Melrose, Mass.; and Greenfield, Mass., among other locations in Massachusetts, Maine and elsewhere.” 

Keep reading

Newsom Protests ICE Raid on Marijuana Farm Allegedly Found Using Child Labor

California Gov. Gavin Newsom protested against an Immigration and Customs Enforcement (ICE) raid on a marijuana farm in his state this week that was allegedly found to have been using child labor.

Newsom reposted a video of the raid, calling President Donald Trump the “real scum” for enforcing the law.

U.S. Customs and Border Protection Commissioner Rodney Scott alleged that the farm had been found employing not only illegal aliens, but also “juveniles.”

Newsom was, in effect, trying to protect child labor.

The governor returned Thursday from a two-day swing to South Carolina, where he is testing the waters for a presidential run in three years’ time by introducing himself to voters in rural counties.

Keep reading

Psychedelic Drug May Slow Aging

Could magic mushrooms hold the key to slowing down aging? New research from Georgia’s Emory University suggests they just might.

A new study has found that psilocin—a compound produced in the body after consuming psilocybin, the active ingredient in psychedelic mushrooms—extended the lifespan of human skin and lung cells in the lab by more than 50 percent.

The researchers also found that mice treated with psilocybin lived 30 percent longer—not to mention more healthily—than their peers.

“This study provides strong preclinical evidence that psilocybin may contribute to healthier aging—not just a longer lifespan, but a better quality of life in later years,” Dr. Ali John Zarrabi, Director of Psychedelic Research at Emory University’s Department of Psychiatry said in a statement.

“As a palliative care physician-scientist, one of my biggest concerns is prolonging life at the cost of dignity and function. But these mice weren’t just surviving longer—they experienced better aging,” added Zarrabi, who co-led the study.

As part of their study, the researchers ran the first long-term assessment of psilocybin’s systemic effects in living animals.

They treated aged, 19-month-old mice—which is something like 60–65 in human years—with an initially low psilocybin dose of 5 mg, followed by a high dose of 15 mg every month for 10 months.

The team found that psilocybin-treated mice survived around 30 percent longer than their untreated peers. Moreover, the treated mice also looked healthier for it, with better fur quality, fewer white hairs and even hair regrowth.

While psilocybin is usually studied for its mental health benefits, the findings suggest that the compound may also tackle key drivers of aging.

According to the team, the psilocybin treatments reduced oxidative stress, improved the cells’ ability to repair DNA and helped preserve the length of telomeres—the protective caps on chromosomes that guard against damage leading to diseases like cancer, neurodegeneration and heart disease.

“Most cells in the body express serotonin receptors, and this study opens a new frontier for how psilocybin could influence systemic aging processes, particularly when administered later in life,” said senior author and former Emory professor Louise Hecker in a statement.

Though psilocybin may be best known for its hallucinogenic effects on the brain, most cells in the body have serotonin receptors, suggesting it could have much wider impacts.

Keep reading

Bipartisan Senators Agree To Delay Planned Federal Hemp Product Ban For One Year

A powerful Senate committee has approved a bill that contains provisions hemp industry stakeholders say would devastate the market by banning consumable hemp products with any “quantifiable” amount of THC. However, bipartisan members agreed to delay the implementation of the ban for one year.

On Thursday, the Senate Appropriations Committee passed Agriculture, Rural Development, FDA spending legislation that covers the next fiscal year—and also includes provisions that would significantly revise hemp laws following the crop’s legalization under the 2018 Farm Bill.

The bill “closes the hemp loophole that has resulted in the proliferation of unregulated intoxicating hemp products being sold across the country,” a committee summary says.

Ahead of the panel vote, several sources told Marijuana Moment that Sen. Mitch McConnell (R-KY), who championed hemp legalization through that 2018 legislation while serving as majority leader, was behind the restrictive cannabis language, vying to redefine his legacy by recriminalizing intoxicating cannabinoid products such as delta-8 THC.

At Thursday’s hearing, Sen. Jeff Merkley (D-OR) said he appreciates McConnell’s concerns but worries that the new prohibition would be overbroad and impact even non-intoxicating products, saying the language “addresses one very important issue, but causes another problem.”

“It’s been a privilege to work with Senator McConnell on hemp,” he said. “We first brought to this committee the idea that research should be done on hemp, and then later we put in an amendment that proceeded to allow seeds to be transferred across states, and now there is a hemp industry.”

“The important issue it addresses is not allowing hemp to be grown to produce hallucinogenic products, and that, unfortunately, due to the magic of laboratories, has occurred,” Merkley said. “But then there are other products that come from hemp such as CBD that has, in fact, been a significant factor as a healthcare supplement in many, many products across America that does not have a hallucinogenic effect.”

“I would like to continue to work with Senator McConnell to see if we can develop, in the course of this year, a definition that addresses hallucinogenic factors but does not eliminate the CBD product that is non hallucinogenic [and] that is valued by many Americans across the land,” he said.

“I know that there’s important work to be done on the hemp, but this one year [delay] will enable our farmers who are growing hemp currently to produce this year’s crop within the existing framework, and we’ll have a conversation over the coming year,” Merkley said.

McConnell appeared less interested in using the year to establish an alternative regulatory framework, saying that he’s simply agreeing to “give our hemp farmers ample time to prepare for their future.”

“The 2018 Farm Bill federally legalized hemp as an agricultural product,” the senator said. “This language had an unintended consequence that has allowed for intoxicating hemp-derived synthetic products to be made and sold across our country.”

“These intoxicating products have flooded the market in the absence—no regulatory structure, and [businesses] often use deceptive and predatory marketing towards children with packaging and logos similar to existing food products such as Oreos, candy, gummies and cereals,” McConnell said.

“The way I see it, the language I helped secure takes us back to the original intent of the 2018 Farm Bill, and closes this loophole,” the former Senate majority leader said, adding that the hemp provisions prior agriculture legislation “sought to create an agricultural hemp industry—not open the door to the sale of unregulated, intoxicating lab-made, hemp-derived substances with no safety framework.”

The hemp language in the new Senate spending bill is nearly identical to what the House Appropriations Committee passed late last month, with noted cannabis prohibitionist Rep. Andy Harris (R-MD) leading the charge.

Keep reading

Medical Marijuana Reduces Anxiety And Depression, New Federally Funded Study Shows

Medical marijuana was associated with “significant decreases in self-reported anxiety and depression” compared to before patients began treatment with cannabis, according to a new study funded in part by the National Institute on Drug Abuse (NIDA).

The observational study, published this month in the Journal of Affective Disorders, looked at 33 adults in Maryland with “clinically significant” anxiety and/or depression over a six-month period, evaluating them at baseline, and then again after one, three and six months from when patients began using medical cannabis.

“Significant decreases from baseline in anxiety and depression were observed, with mean scores dropping below clinically significant levels within three months of initiation,” the study says. Participants also reported sustained reductions in anxiety and/or depression symptoms over the six-month study period.

Most patients chose THC-dominant cannabis products. In addition to self-reported benefits to mental health, they also reported a decline in their perceived driving ability and an increase in feeling high.

“Acute effects were dose-dependent,” authors wrote: “10–15 mg of oral THC and at least 3 puffs of vaporized cannabis yielded the most robust reductions in anxiety and depression.”

Among participants, three-quarters said they had previously used marijuana. Just over a third (37 percent) said they’d used cannabis within the past year.

At the time of the study, medical marijuana was legal in Maryland but the substance remained illegal for nonmedical use.

The six-person team behind the new study represents the Johns Hopkins University School of Medicine, the Johns Hopkins School of Public Health and the university’s Sidney Kimmel Comprehensive Cancer Center, as well as the Centre for Alcohol Policy Research in Melbourne, Australia.

A conflict of interest section of the report notes that some members have received funding or currently work for companies involved in medical marijuana.

In addition to NIDA funding, the project also received support a pilot grant from the Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University.

Authors said that while the findings of the new study were promising, “controlled clinical trials are needed to further investigate the efficacy and safety of medicinal cannabis for acute anxiety and depression symptom management.”

Keep reading

Former CBP Officer Sentenced for Smuggling Cocaine from the U.S. Virgin Islands to Atlanta

Ivan Van Beverhoudt, 45, a former U.S. Customs and Border Protection (CBP) officer of St. Thomas, U.S. Virgin Islands, will serve a 20-year prison sentence following his convictions for importing and possessing with intent to distribute over 15 kilograms of cocaine.

“Van Beverhoudt betrayed his badge by committing one of the very crimes he was entrusted to prevent—smuggling dangerous drugs into our country,” said U.S. Attorney Theodore S. Hertzberg. “Our office and its agency partners will hold accountable any law enforcement officer who abuses his authority for criminal ends, and Van Beverhoudt’s twenty-year sentence demonstrates that such abuse will be met with severe consequences.”

“This case highlights the severe repercussions for law enforcement officers who abuse their positions of trust,” said Steven N. Schrank, the Special Agent in Charge of Homeland Security Investigations (HSI) in Georgia and Alabama. “Ivan Van Beverhoudt’s attempt to smuggle over 15 kilograms of cocaine into the country was a grave violation, and thanks to the efforts of HSI and our partners, he will spend 20 years behind bars.”

According to U.S. Attorney Hertzberg, the charges, and other information presented in court: On January 10, 2020, Van Beverhoudt, a CBP officer, boarded a commercial flight from St. Thomas to Atlanta with 16 bricks of cocaine in his two carry-on bags. To avoid TSA screening in St. Thomas, Van Beverhoudt traveled in his official capacity with his loaded CBP-issued firearm. Upon arriving at the Atlanta Hartsfield-Jackson International Airport, a CBP-trained narcotics K-9 officer in the jetway alerted to Van Beverhoudt’s luggage, which led to the discovery of the cocaine. 

On February 24, 2025, following a five-day jury trial, Van Beverhoudt was convicted of conspiracy to import cocaine into the United States, importation of cocaine into the United States, conspiracy to possess with intent to distribute cocaine, and possession with intent to distribute cocaine. 

On July 8, 2025, United States District Judge J.P. Boulee sentenced Van Beverhoudt to 20 years in prison to be followed by five years of supervised release. 

This case was investigated by U.S. Immigration and Customs Enforcement’s Homeland Security Investigations, with valuable assistance provided by U.S. Customs and Border Protection and the Department of Homeland Security, Office of the Inspector General. 

Keep reading

Hawaii Governor Signs Law Requiring Hemp Retailers to Register With State, Sets Age Restriction on Tinctures

The law, HB 1482, was signed on July 2 and will take effect January 1, 2026. It restricts sales of hemp-derived tinctures to those 21 and older, aligning the product category with rules for adult-use substances.

In addition to the registration requirement, the law grants health officials the authority to inspect facilities involved in hemp sales and distribution and to confiscate noncompliant products. It also makes clear that violations may be prosecuted under the state’s laws on unfair or deceptive practices, unfair competition, and nuisance abatement.

Oversight of hemp processing will fall to the Office of Medical Cannabis Control and Regulation, which will administer a new program specifically for hemp processors. Registration fees and other costs tied to implementation will be funded through Hawaii’s Hemp Processing Special Fund.

Keep reading

Study: CBD Inhibits Osteosarcoma by Targeting Tumor-Driving Inflammation

“Osteosarcoma remains a therapeutic challenge due to its aggressive behavior and high metastatic potential, necessitating exploration of novel treatment modalities”, states the study’s abstract. “Cannabidiol (CBD), a non-psychoactive phytocannabinoid with emerging anticancer properties, has shown promise in preclinical cancer models. However, its mechanisms of action in osteosarcoma remain incompletely understood.”

With that in mind, “This study systematically investigates the antitumor effects of CBD on osteosarcoma and elucidates its molecular targets within the TNF-α/NF-κB/CCL5 signaling axis.”

Conducted by researchers at Shandong University and Harbin Medical University, researchers used cell-based assays and a mouse model, finding that CBD suppressed osteosarcoma cell proliferation, migration, and invasion, while also reducing tumor growth in vivo.

The team identified that CBD binds directly to the NF-κB subunit p65, blocking its ability to activate transcription of the chemokine CCL5. This disruption also interfered with a previously unrecognized positive feedback loop between p65 and CCL5, which helps sustain inflammatory signaling in osteosarcoma cells. By targeting this loop, CBD not only inhibited tumor-promoting inflammation but also weakened the cancer’s ability to proliferate and spread.

The researchers used a combination of molecular docking, protein-binding assays, and gene expression analysis to confirm CBD’s direct interaction with the p65 protein and its downstream effects.

Keep reading

FDACS removes over 85K illegal hemp products in child safety crackdown

Florida Agriculture Commissioner Wilton Simpson announced results of “Operation Safe Summer,” a statewide enforcement effort resulting in the removal of more than 85,000 hemp packages that were found in violation of state child-protection standards.

In the first three weeks of the operation, hemp-derived products were seized across 40 counties for “violations of Florida’s child-protection standards for packaging, labeling, and marketing,” according to a press release from the Department of Agriculture and Consumer Services.

Simpson said they will continue to “aggressively enforce the law, hold bad actors accountable, and put the safety of Florida’s families over profits.”

The state previously issued announcements advising hemp food establishments on the planned enforcement of amendments to Rule 5K-4.034, Florida Administrative Code, a press release said.

Keep reading

GOP Senator Who Helped Federally Legalize Hemp Is Seeking To Close ‘Loophole’ By Banning Products With Committee Vote This Week, Sources Say

The senator who championed the federal legalization of hemp is now seeking to reverse much of the reform by pushing legislation at a committee hearing this week to ban on consumable products with quantifiable amounts of THC, industry stakeholders say.

Several sources told Marijuana Moment on Tuesday that Sen. Mitch McConnell (R-KY), the former majority leader in the Senate who led the push for hemp legalization as part of the 2018 Farm Bill, is behind forthcoming language in agriculture spending legislation that would effectively wipe out the consumable hemp product market.

The bill text has not been released at this point, however, and there are efforts within the cannabis space to get it amended before it goes to a vote in the Senate Appropriations Committee on Thursday. Marijuana Moment reached out to McConnell’s office for comment, but representatives did not respond by the time of publication.

Two of the sources said that the hemp provisions will be identical to what the House Appropriations Committee passed late last month, with noted cannabis prohibitionist Rep. Andy Harris (R-MD) leading the charge to correct what he’s described as a “loophole” in the Farm Bill that led to the proliferation of consumable—and in certain cases intoxicating—cannabinoid products such as delta-8 THC that have gone largely unregulated.

Another source said McConnell is aware that hemp legalization is part of his legacy in the Senate and wants closing the so-called “loophole” that has allowed the proliferation of intoxicating products to be part of that history.

Industry experts say the language wouldn’t just ban controversial hemp products found at gas stations and headshops across the country, however. Based on the House text, it would prohibit all products containing any amount of THC, and the concern is that it would mean even CBD items would likely be banned because it’s extremely rare that the extraction of that non-intoxicating cannabinoid would have no THC.

Sen. Rand Paul (R-KY) told Marijuana Moment recently that he’s opposed to cannabis language included in the House agriculture appropriations bill that’s now heading to the floor. He said “I think would completely destroy the American hemp industry.”

“I don’t know how you’d be able to sell CBD oil with that,” he the senator said.

While Harris amended report language attached to the bill that clarifies it’s not the intent of the committee to stop people from accessing “industrial or nonintoxicating hemp-derived cannabinoid products with trace or insignificant amounts of THC,” the House bill itself still says that products containing any “quantifiable” amounts of THC couldn’t be marketed. And it’s rare to find CBD items without any natural traces of THC.

Again, while industry sources familiar with the discussions say the Senate version will contain identical language in its current form, the text isn’t publicly available and it’s possible it could be revised ahead of Thursday’s committee markup. But if the language is the same, that would raise serious concerns in the hemp sector, significantly increasing the likelihood that it could be enacted into law.

Keep reading